Pharmaco Industries Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 8669.17%
- Profit Growth 164.78%
- Net Worth 69.99%
- Total Assets 39.37%
About Pharmaco Industries
Pharmaco Industries Private Limited (PIPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 18 December 2020 (Four years and one month 21 days old ). Its registered office is in Indore, Madhya Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Mamta Malpani, Akshay Malpani, and Rohit Malpani serve as directors at the Company.
Company Details
-
Location
Indore, Madhya Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999MP2020PTC054187
-
Company No.
054187
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
18 Dec 2020
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Gwalior
Industry
Who are the key members and board of directors at Pharmaco Industries?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mamta Malpani
|
Director | 18-Dec-2020 | Current |
|
Akshay Malpani
|
Director | 18-Dec-2020 | Current |
|
Rohit Malpani
|
Director | 18-Dec-2020 | Current |
Financial Performance of Pharmaco Industries.
Pharmaco Industries Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 8669.17% increase. The company also saw a substantial improvement in profitability, with a 164.78% increase in profit. The company's net worth Soared by an impressive increase of 69.99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pharmaco Industries?
Unlock access to Pharmaco Industries's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Krishna Builders Pvt LtdMamta Malpani is a mutual person
-
Sukrut Realbuild Private Limited
Mamta Malpani and Rohit Malpani are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pharmaco Industries?
Unlock and access historical data on people associated with Pharmaco Industries, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pharmaco Industries, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharmaco Industries's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.